A novel transcatheter-implanted system that shunts blood flow from the left to right atrium through the coronary sinus has ...

At this time, I would like to welcome everyone to the DaVita fourth quarter 2024 earnings call. All lines have been placed on ...

Using the BiovitalsHF software to personalize recommendations got more patients on all four pillars of therapy.

Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ETCompany ParticipantsNic Eliason - Group VP, IRJavier Rodriguez - ...

Pushkal Garg; Chief Medical Officer, Executive Vice President - Development and Medical Affairs; Alnylam Pharmaceuticals Inc Jeffrey Poulton; Chief Financial Officer, Executive Vice President; Alnylam ...

HealthCare Partners Inc. (DVA) reported better-than-expected earnings for the fourth quarter of 2024, with an adjusted earnings per share (EPS) of $2.24, surpassing the forecasted $2.13. Revenue also ...